Literature DB >> 20485312

Molecular therapeutics from knowledge to delivery.

S A Waldman, A Terzic.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20485312     DOI: 10.1038/clpt.2010.61

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  8 in total

1.  Clinical and translational science: from bench-bedside to global village.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

2.  Chronic diseases: the emerging pandemic.

Authors:  Andre Terzic; Scott Waldman
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

3.  Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

Review 4.  K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.

Authors:  D Kent Arrell; Jelena Zlatkovic Lindor; Satsuki Yamada; Andre Terzic
Journal:  Cardiovasc Res       Date:  2011-02-14       Impact factor: 10.787

5.  Bionic technologies transforming the science of healthcare delivery.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2011-04       Impact factor: 4.689

6.  Advancing pharmacometrics and systems pharmacology.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2012-11       Impact factor: 6.875

7.  Clinical pharmacology at the core of translational science.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

8.  Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations.

Authors:  Andre Terzic; Alexey E Alekseev; Satsuki Yamada; Santiago Reyes; Timothy M Olson
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.